Published in
Taylor and Francis Group, Cancer Investigation, 6(34), p. 265-270
DOI: 10.1080/07357907.2016.1193746
Links
Tools
A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors
Journal article published in 2016 by
Johanna C. Bendell,
Todd M. Bauer 
,
Ruth Lamar,
Mathew Joseph,
William Penley,
Dana S. Thompson,
David R. Spigel,
Rami Owera,
Cassie M. Lane,
Chris Earwood,
Howard A. Burris
,
Ruth Lamar,
Mathew Joseph,
William Penley,
Dana S. Thompson,
David R. Spigel,
Rami Owera,
Cassie M. Lane,
Chris Earwood,
Howard A. Burris
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 